SEC Filings | Enanta Pharmaceuticals, Inc.

SEC Filings

Filing date	Form	Description	Filing Group	View
Mar 20, 2013	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0000908662-13-000139.pdf 0000908662-13-000139.rtf 0000908662-13-000139.xls
Mar 20, 2013	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001012975-13-000118.pdf 0001012975-13-000118.rtf 0001012975-13-000118.xls
Mar 20, 2013	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001012975-13-000119.pdf 0001012975-13-000119.rtf 0001012975-13-000119.xls
Mar 20, 2013	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001181431-13-018091.pdf 0001181431-13-018091.rtf 0001181431-13-018091.xls
Mar 20, 2013	EFFECT	EFFECT	Other	View HTML 9999999995-13-000755.pdf 9999999995-13-000755.rtf 9999999995-13-000755.xls
Mar 19, 2013	CERTNAS	CERTNAS	Other	View HTML 9999999997-13-005871.pdf 9999999997-13-005871.rtf
Mar 18, 2013	CORRESP	CORRESP	Other	View HTML 0001193125-13-111524.pdf 0001193125-13-111524.rtf 0001193125-13-111524.xls
Mar 18, 2013	CORRESP	CORRESP	Other	View HTML 0001193125-13-111530.pdf 0001193125-13-111530.rtf 0001193125-13-111530.xls
Mar 18, 2013	8-A12B	Registration of certain classes of securities 12(b) of the Securities Exchange Act	Registration Statements	View HTML 0001193125-13-111475.pdf 0001193125-13-111475.rtf 0001193125-13-111475.xls
Mar 14, 2013	UPLOAD	UPLOAD	Other	View HTML 0000000000-13-013674.pdf

Data provided by Kaleidoscope.